Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable?
Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable? · Investor's Business Daily

In This Article:

Pfizer tock edged lower Tuesday on a "pretty uneventful quarter" as revenue from its Covid products helped drive a fourth-quarter beat.